These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 11100730)

  • 21. PrP(Sc) of scrapie 263K propagates efficiently in spleen and muscle tissues with protein misfolding cyclic amplification.
    Shi S; Dong CF; Wang GR; Wang X; An R; Chen JM; Shan B; Zhang BY; Xu K; Shi Q; Tian C; Gao C; Han J; Dong XP
    Virus Res; 2009 Apr; 141(1):26-33. PubMed ID: 19162101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice.
    Pfeifer A; Eigenbrod S; Al-Khadra S; Hofmann A; Mitteregger G; Moser M; Bertsch U; Kretzschmar H
    J Clin Invest; 2006 Dec; 116(12):3204-10. PubMed ID: 17143329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary myopathy and accumulation of PrPSc-like molecules in peripheral tissues of transgenic mice expressing a prion protein insertional mutation.
    Chiesa R; Pestronk A; Schmidt RE; Tourtellotte WG; Ghetti B; Piccardo P; Harris DA
    Neurobiol Dis; 2001 Apr; 8(2):279-88. PubMed ID: 11300723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficient inhibition of prion replication by PrP-Fc(2) suggests that the prion is a PrP(Sc) oligomer.
    Masel J; Genoud N; Aguzzi A
    J Mol Biol; 2005 Feb; 345(5):1243-51. PubMed ID: 15644218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prion inactivation by the Maillard reaction.
    Suyama K; Yoshioka M; Akagawa M; Murayama Y; Horii H; Takata M; Yokoyama T; Mohri S
    Biochem Biophys Res Commun; 2007 Apr; 356(1):245-8. PubMed ID: 17336934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperefficient PrP Sc amplification of mouse-adapted BSE and scrapie strain by protein misfolding cyclic amplification technique.
    Fujihara A; Atarashi R; Fuse T; Ubagai K; Nakagaki T; Yamaguchi N; Ishibashi D; Katamine S; Nishida N
    FEBS J; 2009 May; 276(10):2841-8. PubMed ID: 19459939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methionine sulfoxides on PrPSc: a prion-specific covalent signature.
    Canello T; Engelstein R; Moshel O; Xanthopoulos K; Juanes ME; Langeveld J; Sklaviadis T; Gasset M; Gabizon R
    Biochemistry; 2008 Aug; 47(34):8866-73. PubMed ID: 18680312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of monoclonal antibody that distinguishes PrPSc from PrPC and neutralizes prion infectivity.
    Horiuchi M; Karino A; Furuoka H; Ishiguro N; Kimura K; Shinagawa M
    Virology; 2009 Nov; 394(2):200-7. PubMed ID: 19766283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lithium induces clearance of protease resistant prion protein in prion-infected cells by induction of autophagy.
    Heiseke A; Aguib Y; Riemer C; Baier M; Schätzl HM
    J Neurochem; 2009 Apr; 109(1):25-34. PubMed ID: 19183256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthetic fibril peptide promotes clearance of scrapie prion protein by lysosomal degradation.
    Okemoto-Nakamura Y; Yamakawa Y; Hanada K; Tanaka K; Miura M; Tanida I; Nishijima M; Hagiwara K
    Microbiol Immunol; 2008 Jul; 52(7):357-65. PubMed ID: 18667034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preventing misfolding of the prion protein by trimethylamine N-oxide.
    Bennion BJ; DeMarco ML; Daggett V
    Biochemistry; 2004 Oct; 43(41):12955-63. PubMed ID: 15476389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strategies for eliminating PrP(c) as substrate for prion conversion and for enhancing PrP(Sc) degradation.
    Gilch S; Nunziante M; Ertmer A; Schätzl HM
    Vet Microbiol; 2007 Aug; 123(4):377-86. PubMed ID: 17493775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of prion disease progression: a chemical reaction network approach.
    Méndez JM; Femat R
    IET Syst Biol; 2011 Nov; 5(6):347-52. PubMed ID: 22129030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breakage of PrP aggregates is essential for efficient autocatalytic propagation of misfolded prion protein.
    Piening N; Weber P; Giese A; Kretzschmar H
    Biochem Biophys Res Commun; 2005 Jan; 326(2):339-43. PubMed ID: 15582583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assembly of natural and recombinant prion protein into fibrils.
    Leffers KW; Wille H; Stöhr J; Junger E; Prusiner SB; Riesner D
    Biol Chem; 2005 Jun; 386(6):569-80. PubMed ID: 16006244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induced neuroprotection independently from PrPSc accumulation in a mouse model for prion disease treated with simvastatin.
    Haviv Y; Avrahami D; Ovadia H; Ben-Hur T; Gabizon R; Sharon R
    Arch Neurol; 2008 Jun; 65(6):762-75. PubMed ID: 18541796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Infectivity-associated PrP(Sc) and disease duration-associated PrP(Sc) of mouse BSE prions.
    Miyazawa K; Okada H; Masujin K; Iwamaru Y; Yokoyama T
    Prion; 2015; 9(5):394-403. PubMed ID: 26555211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Towards cellular receptors for prions.
    Lee KS; Linden R; Prado MA; Brentani RR; Martins VR
    Rev Med Virol; 2003; 13(6):399-408. PubMed ID: 14625887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An improved method for cell-to-cell transmission of infectious prion.
    Tanaka M; Hara H; Nishina H; Hanada K; Hagiwara K; Maehama T
    Biochem Biophys Res Commun; 2010 Jul; 397(3):505-8. PubMed ID: 20515650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurodevelopmental expression and localization of the cellular prion protein in the central nervous system of the mouse.
    Benvegnù S; Poggiolini I; Legname G
    J Comp Neurol; 2010 Jun; 518(11):1879-91. PubMed ID: 20394048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.